In addition, non-response PBC patients who received long-term UDCA therapy would allow us to evaluate the effect of ERα antagonism, which had been exerted a rational therapeutic strategy in sex-based mortality gap in cystic fibrosis and other inflammatory lung illnesses (54). Here, ESR1 is linked to primary biliary cholangitis.